Our History

The Continuously Growing EPS Group

The history of EPS Group begins with the dawn of the CRO business, in 1991. From there, we gradually expanded the scope of our business activities, adding SMO and CSO services, and eventually becoming a comprehensive provider of a broad range of drug development and other support services for the healthcare industry. We began to expand into China and other overseas markets early in our history and are now a valued partner in the globalization of new drug development.

1991 EPS Tokyo Inc. was established for Clinical trials related software development & Sales.
  • Launched CRO (Contract Research Organization) business by starting case registration and drug allocation services for clinical trials.
  • Developed a large-scaled clinical trial support system for the drug pharmaco-epidemiology research by Ministry of Health and Welfare (currently, MHLW).
1996 Changed the company name to EPS Co., Ltd.
  • Launched CRO and software development business in China.
  • Launched SMO (Site Management Organization) business to support clinical trial-related operations of medical institutions.
2000 Started CSO (Contract Sales Organization) business, which undertakes MR (Medical Representative) operations for pharmaceutical companies.
  • Changed the company name to EPS Corporation
  • EPS Corporation listed on JASDAQ.
2003 Launched CRO business in Southeast Asia
2006 EPS Corporation listed on the 1st section of the Tokyo Stock Exchange.
2010 Started Pharmaceutical products sales business in China.
2015 Transferred to a holding company system and changed the company name to EPS Holdings, Inc.
2016 Capital and business alliance agreement with SUZUKEN CO., LTD.
2020 Participation in joint development of DNA vaccine for new coronavirus (COVID-19).
  • 30th anniversary of the foundation.
  • MBO implemented and unlisted.

Page Top